logo

For the Inventor, By the Inventor

Villeneuve-Loubet, France

Claude Laruelle

This inventor holds 24 USPTO granted patents and 3 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Cll Pharma, Panmedica, Panmedica S.a.. Active years: 1983-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claude Laruelle. Retrieved from https://idiyas.com/inventor/claude-laruelle

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 24

% Patents Active = 79.2

 

Average Co-Inventor Count = 2.2

ph-index = 8

Forward Citations = 629(Granted Patents)


Location History:

  • 06270 Villeneuve-Loubet, FR (1987 - 1992)
  • Villeneuve Loubet, FR (1983 - 2016)
  • Nice, FR (2016)

Company Filing History:

goldMedal5 out of 5 
 
Cll Pharma
 patents
silverMedal4 out of 4 
 
Panmedica
 patents
bronzeMedal4 out of 6 
 
Panmedica S.a.
 patents
4. 3 out of 3 
 
S. a. Panmedica
 patents
5. 1 out of 1 
 
Ccl Pharma
 patent
6. 1 out of 1 
 
Laboratoires Panmedica
 patent
7. 1 out of 1 
 
Orphit
 patent
8. 1 out of 14 
 
Virbac Sa
 patents
9. 4 out of 834,601 
Other
 patents

Years Active: 1983-2016

Loading Chart...
Loading Chart...
Areas of Expertise:
Nanopeptides
Neurodegenerative Diseases
Autoimmune Diseases
Pharmaceutical Dosage
Galenic Formulations
Dispersible Compounds
Antibacterial Agents
Amino Acid Esters
Injection Devices
Serotonin Increasers
Trimethylcyclohexyl Derivatives
Dipeptides
24 patents (USPTO):Explore Patents
1. 9468662 - Use of the PAT nonapeptide in the treatment and prevention of neurodegenerative diseases (2016-10-18),
2. 9427455 - Use of the pat nanopeptide in the treatment of autoimmune diseases (2016-08-30),
3. 9192654 - Use of the PAT nanopeptide in treating and preventing neurodegenerative diseases (2015-11-24),
4. 9029390 - Oral composition containing an antiplatelet agent of the thienopyridine family in the form of free base (2015-05-12),
5. 6669957 - Galenic formulations fast disintegrating in the mouth and method for preparing same (2003-12-30),
6. 6605301 - Dispersible macrolide compounds and method for production thereof (2003-08-12),
7. 5827536 - Pharmaceutical dosage formulations of fenofibrate and their applications (1998-10-27),
8. 5527523 - Hydroquinone amino-acid esters, methods of preparation, and (1996-06-18),
9. 5310757 - 3,3,5-trimethylcyclohexyl 2-methylpropionate derivatives, their method (1994-05-10),
10. 5236946 - Amino acid esters of cycloaliphatic alcohols and their use in treating (1993-08-17),
11. 5141496 - Spring impelled syringe guide with skin penetration depth adjustment (1992-08-25),
12. 5134157 - Amino acid of cycloaliphatic alcohols, process for their preparation and (1992-07-28),
13. 5074843 - Device for subcutaneous injection without a needle (1991-12-24),
14. 4804684 - Symmetrical O-substituted dioximes of benzo-fused (1989-02-14),
15. 4794121 - Alkylcarboxamides of pyridylalkylamines, and their use in human and (1988-12-27),

Title: Claude Laruelle - Innovative Inventor from Villeneuve-Loubet

Introduction: Claude Laruelle is a renowned inventor hailing from Villeneuve-Loubet, France, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Claude Laruelle holds several patents in the areas of renewable energy, sustainable materials, and advanced robotics, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Claude Laruelle has worked with leading research institutions and universities to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Claude Laruelle has collaborated with top companies, innovative startups, and talented individuals to bring his inventions to life, fostering a culture of creativity and innovation.

Conclusion: Claude Laruelle's passion for innovation and dedication to pushing the boundaries of what is possible have solidified his reputation as a visionary inventor in the global tech community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…